![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/519 | |
A61K 45/06 | |||
A61P 35/00 |
(11) | Number of the document | 2976086 |
(13) | Kind of document | T |
(96) | European patent application number | 14768267.8 |
Date of filing the European patent application | 2014-03-21 | |
(97) | Date of publication of the European application | 2016-01-27 |
(45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/031442 |
Date | 2014-03-21 |
(87) | Number | WO 2014/153509 |
Date | 2014-09-25 |
(30) | Number | Date | Country code |
201361804314 P | 2013-03-22 | US |
(72) |
BRAKE, Rachel, US
NIU, Huifeng, US
|
(73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
(54) | COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |
COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |